XML 114 R65.htm IDEA: XBRL DOCUMENT v3.25.0.1
Restructuring - Narrative (Details)
employee in Thousands, $ in Millions
12 Months Ended
Sep. 26, 2023
USD ($)
ft²
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
employee
Maximum      
Restructuring Cost and Reserve [Line Items]      
Expected cost remaining     $ 280.0
Operating lease, contract term   14 years  
Minimum      
Restructuring Cost and Reserve [Line Items]      
Expected cost remaining     $ 260.0
Operating lease, contract term   1 year  
2023 Cost Saving Initiatives      
Restructuring Cost and Reserve [Line Items]      
Expected operating expense reduction $ 1,000.0    
Expected number of positions eliminated | employee     1
Reata Integration      
Restructuring Cost and Reserve [Line Items]      
Expected cost   $ 35.0  
Reata Pharmaceuticals, Inc      
Restructuring Cost and Reserve [Line Items]      
Operating lease area | ft² 327,400    
Operating lease, contract term 16 years    
Human Immunology Biosciences      
Restructuring Cost and Reserve [Line Items]      
Integration related costs   $ 2.6